Correlation Between Inhibrx and Cardinal Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Cardinal Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Cardinal Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Cardinal Health, you can compare the effects of market volatilities on Inhibrx and Cardinal Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Cardinal Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Cardinal Health.

Diversification Opportunities for Inhibrx and Cardinal Health

-0.49
  Correlation Coefficient

Very good diversification

The 3 months correlation between Inhibrx and Cardinal is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Cardinal Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardinal Health and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Cardinal Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardinal Health has no effect on the direction of Inhibrx i.e., Inhibrx and Cardinal Health go up and down completely randomly.

Pair Corralation between Inhibrx and Cardinal Health

Given the investment horizon of 90 days Inhibrx is expected to under-perform the Cardinal Health. In addition to that, Inhibrx is 4.01 times more volatile than Cardinal Health. It trades about -0.02 of its total potential returns per unit of risk. Cardinal Health is currently generating about 0.45 per unit of volatility. If you would invest  11,650  in Cardinal Health on October 20, 2024 and sell it today you would earn a total of  977.00  from holding Cardinal Health or generate 8.39% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Inhibrx  vs.  Cardinal Health

 Performance 
       Timeline  
Inhibrx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inhibrx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental drivers remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Cardinal Health 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cardinal Health are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite fairly inconsistent basic indicators, Cardinal Health demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Inhibrx and Cardinal Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inhibrx and Cardinal Health

The main advantage of trading using opposite Inhibrx and Cardinal Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Cardinal Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardinal Health will offset losses from the drop in Cardinal Health's long position.
The idea behind Inhibrx and Cardinal Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Commodity Directory
Find actively traded commodities issued by global exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format